Compare BTM & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTM | ELUT |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | 135 | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 48.3M |
| IPO Year | N/A | 2020 |
| Metric | BTM | ELUT |
|---|---|---|
| Price | $0.57 | $1.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.10 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 703.5K | 128.5K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.33 | $10.83 |
| P/E Ratio | $3.52 | ★ $1.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $0.50 |
| 52 Week High | $8.30 | $2.60 |
| Indicator | BTM | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 23.93 | 54.44 |
| Support Level | N/A | $1.00 |
| Resistance Level | $1.69 | $1.18 |
| Average True Range (ATR) | 0.62 | 0.08 |
| MACD | -0.67 | 0.01 |
| Stochastic Oscillator | 0.33 | 63.64 |
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.